semaglutide digestive blockage class action in kentucky OZEMPIC FEET": As GLP-1 drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: "Ozempic feet." Read the full story the link in our semaglutide bowel obstruction class action

For insulin-resistant patients, this dual actionappetite reduction plus metabolic improvementaddresses the root problem rather than forcing the body to fight against its own hormonal imbalance

Hair that's being forced out by tissue that's too old to hold it

Tesofensine at doses of 0.25 mg, 0.5 mg, and 1.0 mg led to average weight losses of 4.5%, 9.2%, and 10.6%, respectively, which were significantly higher than the weight loss achieved with the diet and placebo alone

However, they aren't without adverse reactions, and they carry rare, but significant, risks

Internet: (accessed Feb 2, 2026)

Once a medicine passes its expiry date, there is no guarantee that it retains its intended therapeutic effect or remains safe for consumption